These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16000891)

  • 41. [Relationship between post-stenting coronary thrombolysis in myocardial infarction flow and plasma von Willebrand factor and ADAMTS-13 levels in patients with ST segment elevation myocardial infarction].
    Zhou Q; Li J; Luo XP; Shi HM; Chen H; Zhao BL; Zhu J; Ni HC; Shen W; Wang CP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):212-6. PubMed ID: 21609524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial.
    Gabriel HM; Oliveira JA; da Silva PC; da Costa JM; da Cunha JA
    Catheter Cardiovasc Interv; 2006 Aug; 68(2):218-24. PubMed ID: 16817177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
    Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
    Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Sun Y; Qi G; Gao Y; Zhang H; Pang X; Zhao W; Zhang Z
    Can J Cardiol; 2010 Nov; 26(9):481-5. PubMed ID: 21076721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
    Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation of corrected thrombolysis in myocardial infarction frame count and ST-segment resolution to myocardial tissue perfusion after acute myocardial infarction.
    Li CM; Zhang XH; Ma XJ; Zhu XL
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):312-7. PubMed ID: 18288744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.
    Toso A; Leoncini M; Maioli M; Gallopin M; Tedeschi D; Amato M; Bellandi F
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):318-21. PubMed ID: 21045713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.
    Briguori C; Visconti G; Focaccio A; Golia B; Chieffo A; Castelli A; Mussardo M; Montorfano M; Ricciardelli B; Colombo A
    J Am Coll Cardiol; 2009 Dec; 54(23):2157-63. PubMed ID: 19664895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).
    Shimomura M; Oyama J; Takeuchi M; Shibata Y; Yamamoto Y; Kawasaki T; Komoda H; Kodama K; Sakuma M; Toyoda S; Inoue Y; Mine D; Natsuaki M; Komatsu A; Hikichi Y; Yamagishi S; Inoue T; Node K
    Heart Vessels; 2016 Oct; 31(10):1583-9. PubMed ID: 26699899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
    Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
    Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction.
    Hamada S; Nishiue T; Nakamura S; Sugiura T; Kamihata H; Miyoshi H; Imuro Y; Iwasaka T
    J Am Coll Cardiol; 2001 Sep; 38(3):666-71. PubMed ID: 11527614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction.
    Bax M; de Winter RJ; Schotborgh CE; Koch KT; Meuwissen M; Voskuil M; Adams R; Mulder KJ; Tijssen JG; Piek JJ
    J Am Coll Cardiol; 2004 Feb; 43(4):534-41. PubMed ID: 14975460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
    Patti G; Chello M; Pasceri V; Colonna D; Nusca A; Miglionico M; D'Ambrosio A; Covino E; Di Sciascio G
    J Am Coll Cardiol; 2006 Oct; 48(8):1560-6. PubMed ID: 17045888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.
    Arsenault BJ; Barter P; DeMicco DA; Bao W; Preston GM; LaRosa JC; Grundy SM; Deedwania P; Greten H; Wenger NK; Shepherd J; Waters DD; Kastelein JJ;
    J Am Coll Cardiol; 2011 Jan; 57(1):63-9. PubMed ID: 21185503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.
    Bajaj RR; Mohammad A; Hong T; Irfan A; Sharieff W; Bagnall A; Christie JA; Kutryk MJ; Chisholm RJ; Cheema AN
    J Invasive Cardiol; 2010 Aug; 22(8):347-52. PubMed ID: 20679668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.
    Martínez-Ríos MA; Rosas M; González H; Peña-Duque MA; Martínez-Sánchez C; Gaspar J; García H; Gaxiola E; Delgado L; Carrillo J; Leyva JL; Lupi E;
    Am J Cardiol; 2004 Feb; 93(3):280-7. PubMed ID: 14759375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.
    Rouleau J
    Am J Med; 2005 Dec; 118 Suppl 12A():28-35. PubMed ID: 16356805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials.
    Liu Y; Su Q; Li L
    Clin Cardiol; 2013 Dec; 36(12):E41-8. PubMed ID: 24038054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Mehta RH; Harjai KJ; Cox D; Stone GW; Brodie B; Boura J; O'Neill W; Grines CL;
    J Am Coll Cardiol; 2003 Nov; 42(10):1739-46. PubMed ID: 14642681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.